---
layout: post
title: "罗氏制药双特异性Vabysmo在日本获得批准"
date: 2022-03-29 00:20:05 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/153.RHHBY" data-code="RHHBY|153|-1" data-code2="RHHBY|153|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=153.RHHBY&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 RHHBY_0" data-code="K RHHBY|153|-1" data-code2="K RHHBY|153|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>罗氏制药双特异性Vabysmo在日本获得批准，该药品用于湿性AMD、糖尿病性黄斑水肿，之前已经获得美国食品药品管理局(FDA)批准。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203292325448717>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)